🔗 Share this article

A shadow market for unlicensed weight-loss medications is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Investigational Treatment Gaining Traction Online

Retatrutide, which is still in research studies, is being promoted by online personalities for its supposed weight-reducing properties. Followers are encouraged to contact these profiles directly for source information, while also receiving promotional offers.

Thriving Commerce on Messaging Platforms

Separately, a robust trade exists on Telegram, where communities with numerous of participants share comparison images, injection guides and claims of rapid UK delivery. Vendors market the drug there before redirecting buyers to WhatsApp for transactions.

Understanding The Experimental Drug

Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist patients lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.

Healthcare Professionals Voice Worries

However, doctors and chemists have cautions that the sale of what remains an unapproved drug in the UK is a cause for concern and could lead to users administering products of unknown origin.

Several professionals said the demand for the experimental drug could be linked to the rising cost of licensed slimming treatments such as Mounjaro.

Legal Status and Enforcement

Marketing retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that cannot be marketed or supplied for human use under the British medical regulations.

Some influencers attempt to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still violate medicines, advertising, and consumer laws, potentially leading to fines, legal action or prison.

Platform Reaction and Content Elimination

According to TikTok, the platform has taken down violative content and banned related keywords and search suggestions. The company said it was dedicated to keeping the platform safe and allocating resources in strengthening enforcement strategies.

Online Trading Activities

Investigations also discovered communities with up to 9,000 participants selling retatrutide using Telegram's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” immediately brings up groups with numerous of members, populated with images of weight loss, positive reviews and detailed instructions for preparing or injecting at home.

Within moments of joining one community, a vendor posted contact information, where most purchases take place. The vendor sent an instruction manual and promised delivery within two days. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a image of a alleged testing documentation. None asked about weight, health issues or previous experience.

Item Details and Pricing

Within these communities, posts show dark colored packages with Royal Mail labels, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at residence with sterile water, or ready-to-use pens typically priced at 160 pounds for 20mg. When questioned how long a pen should last, vendors give conflicting responses varying between a few weeks to “depends on your body”.

Platform Moderation and Security Actions

A representative for the messaging service stated it regularly monitored harmful content on its service including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are administering materials they can’t verify. Even if the science behind this drug is valid, these digital products may not contain what they claim,” stated a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of an online medical service linked the surge in demand to recent cost increases for approved weight-loss drugs such as Mounjaro. “With costs increasing, individuals are using online platforms. But counterfeit treatments are highly dangerous. You cannot know what’s inside or whether the conditions they were made in was sterile,” she said.

Her team has already encountered patients injured by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or communication platforms is taking chances with your health,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Statement

A spokesperson from Eli Lilly said the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency globally. “Consequently at this point no one can sell [it] for personal consumption,” they said, noting that any product “falsely representing itself as a Lilly investigational substance not yet approved … may subject patients to possibly significant medical dangers”.